These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8205759)

  • 1. [Intraperitoneal chemotherapy].
    Ficorella C; Ricevuto E; De Rubeis GP; Gabriele A; Marchetti P
    Clin Ter; 1994 Apr; 144(4):367-72. PubMed ID: 8205759
    [No Abstract]   [Full Text] [Related]  

  • 2. The port: delivering intraperitoneal chemotherapy in ovarian cancer.
    Doane LS
    Todays OR Nurse; 1992 Sep; 14(9):11-8. PubMed ID: 1412628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ovarian carcinoma: various aspects of intraperitoneal chemotherapy].
    Los G; Beijnen JH; Dubbelman R; ten Bokkel Huinink WW; McVie JG
    Ned Tijdschr Geneeskd; 1988 Jul; 132(29):1347-50. PubMed ID: 3412503
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraperitoneal chemotherapy for ovarian cancer.
    de Castro G; Snitcovsky IM; Federico MH
    N Engl J Med; 2006 Apr; 354(15):1641-3; author reply 1641-3. PubMed ID: 16615184
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer.
    Marth C; Walker JL; Barakat RR; Casado A; Gadducci A; Miller B; Odicino F; Pujade-Lauraine E; Sehouli J; Tropé C; Wenzel L; Zeimet AG
    Cancer; 2007 Feb; 109(4):645-9. PubMed ID: 17238177
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraperitoneal antineoplastic agents in the management of ovarian cancer.
    Tropé C; Kaern J; Vergote I
    Eur J Surg Suppl; 1991 May; (561):83-6. PubMed ID: 1720054
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraperitoneal chemotherapy: application to upper gastrointestinal neoplasms.
    Howell SB; Zimm S
    Acta Chir Scand Suppl; 1988; 541():16-21. PubMed ID: 3291515
    [No Abstract]   [Full Text] [Related]  

  • 8. "Importance of delivered cycles and nomogram for intraperitoneal chemotherapy in ovarian cancer".
    Markman M
    Gynecol Oncol; 2010 May; 117(2):390; author reply 391. PubMed ID: 20149423
    [No Abstract]   [Full Text] [Related]  

  • 9. Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinoma.
    Trimble EL; Christian MC
    Gynecol Oncol; 2006 Jan; 100(1):3-4. PubMed ID: 16368439
    [No Abstract]   [Full Text] [Related]  

  • 10. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
    Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A
    In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal chemotherapy.
    Markman M
    Semin Oncol; 1991 Jun; 18(3):248-54. PubMed ID: 2042064
    [No Abstract]   [Full Text] [Related]  

  • 12. Ports and complications for intraperitoneal chemotherapy delivery.
    Helm CW
    BJOG; 2012 Jan; 119(2):150-9. PubMed ID: 22017885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal chemotherapy in ovarian carcinoma with the combination of carboplatin and 5-fluorouracil.
    Polyzos A; Giannikos L; Agrafiotis A; Kazaz M; Zonas C; Sfikakis P
    J Chemother; 1989 Jul; 1(4 Suppl):1220-1. PubMed ID: 16312842
    [No Abstract]   [Full Text] [Related]  

  • 14. [Theoretical and experimental bases for intraperitoneal chemotherapy in abdominal neoplastic processes].
    Marinov L
    Khirurgiia (Sofiia); 1986; 39(4):11-7. PubMed ID: 3784379
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
    Petru E; Benedicic Ch; Huell A
    Gynecol Oncol; 2006 Jul; 102(1):129; author reply 130. PubMed ID: 16600354
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraperitoneal therapy for ovarian cancer: why has it not become standard?
    Rowan K
    J Natl Cancer Inst; 2009 Jun; 101(11):775-7. PubMed ID: 19470952
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bowel injury caused by a catheter for Intraperitoneal chemotherapy--a case report].
    Yamauchi I; Higashi M; Yoshioka M; Koyama N; Hashimoto M; Takahashi K; Nakamura Y
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1713-6. PubMed ID: 8886051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.
    Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC
    Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges of IP chemotherapy for ovarian cancer.
    Anselmo-Murphy AM
    Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):21-2. PubMed ID: 19856604
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy delivered into abdomen may extend ovarian cancer survival.
    Mayo Clin Womens Healthsource; 2006 Jun; 10(6):3. PubMed ID: 16675917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.